EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access

Red Blood Cell Exchange Transfusion for Severe Babesiosis

STOP-BABESIOSIS Investigators, David E Leaf, Audrey E Monson, Julie-Alexia Dias, Luis A Marcos, Ulysses Wu, Michael Rossi, Jia H Ng, Rushad Patell, Joshua Hundert, Marc Y El Khoury, James Higgs und 48 weitere

JAMA Internal Medicine · 01.05.2026 · 186 (5) · 597

DOI: 10.1001/jamainternmed.2026.0244 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift JAMA Internal Medicine, erschienen am 01.05.2026. Verfasst von STOP-BABESIOSIS Investigators und 59 weiteren Autor:innen. Beteiligte Einrichtung: Division of Renal Medicine, Brigham and Women's Hospital, Boston, Massachusetts. Hauptthemen laut MEDLINE: Babesiosis, Erythrocyte Transfusion. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Importance Babesiosis is a worldwide emerging tick-borne disease with an expanding geographic range in the US, Europe, and Asia. Red blood cell exchange transfusion (ET) is often used as an adjunctive treatment for severe illness from babesiosis, particularly in patients with high parasitemia, acute organ injury, or severe hemolytic anemia. Data supporting its clinical effectiveness, however, are lacking.

Objective

To test whether ET improves clinical outcomes among hospitalized adult patients with severe babesiosis. Design, Settings, and Participants This target trial emulation used data from a multicenter cohort study of 3233 consecutive adults hospitalized with babesiosis from 2010 to 2024 at 82 sites across the northeastern US. Patients were eligible if they had parasitemia greater than 10%, or 5% to 10% with either acute organ injury or severe hemolytic anemia. Data were analyzed from April to August 2025. Exposure Treatment with ET in the first 7 days of hospitalization. Main Outcomes and Measures A composite of in-hospital death or 30-day readmission. Outcomes were compared between patients who received ET within the first 7 days of admission and those who did not. The analysis used logistic regression, with inverse probability of treatment weighting (IPTW) to adjust for potential confounders.

Results

The analysis included 629 patients (median [IQR] age, 71 [63-79] years; 446 male [70.9%]), among whom 209 (33.2%) received ET in the first 7 days of hospitalization. Patients treated with ET were more severely ill at baseline than those not treated with ET (median parasitemia, 14.0% vs 7.2%); however, severity of illness characteristics were well balanced after applying IPTW. In the main analysis, the primary end point occurred in 3.6% of patients who received ET and in 9.8% who did not (adjusted odds ratio, 0.22; 95% CI, 0.09-0.51). The benefit of ET was confirmed in multiple sensitivity analyses. Conclusions and Relevance This multicenter cohort study found that among severely ill adults hospitalized with babesiosis, the adjusted risk of in-hospital death or 30-day readmission was nearly 5-fold lower in those treated with ET vs those not treated with ET. These data support ET for severely ill patients with babesiosis, although the findings may be susceptible to unmeasured confounding. Further research is needed to identify which patients are most likely to benefit.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BabesiosisErythrocyte TransfusionHumansMaleFemaleMiddle AgedAgedHospital MortalityParasitemiaPatient ReadmissionTreatment OutcomeSeverity of Illness Index

Autor:innen und Institutionen

  • Division of Renal Medicine, Brigham and Women's Hospital, Boston, Massachusetts.
  • Harvard Medical School, Boston, Massachusetts.
  • Department of Biostatistics, Harvard T. H. Chan School of Public Health, Boston, Massachusetts.
  • Division of Infectious Diseases, Stony Brook University, Stony Brook, New York.
  • Division of Infectious Disease, Hartford HealthCare, Hartford, Connecticut.
  • Division of Infectious Diseases, Rhode Island Hospital, Warren Alpert Medical School of Brown University, Providence.

Zitieren

APA

STOP-BABESIOSIS Investigators, Leaf, D. E., Monson, A. E., Dias, J. A., Marcos, L. A., Wu, U., Rossi, M., Ng, J. H., Patell, R., Hundert, J., El Khoury, M. Y., Higgs, J., Smith, R. P., Ramsaroop, V., Green, A., Abdul Azim, A., Weisenberg, S., Kirkman, L. A., Ingram, D., …, & Roy, J. (2026). Red Blood Cell Exchange Transfusion for Severe Babesiosis. JAMA Internal Medicine, 186(5), 597. https://doi.org/10.1001/jamainternmed.2026.0244

Vancouver

STOP-BABESIOSIS Investigators, Leaf DE, Monson AE, Dias JA, Marcos LA, Wu U, et al. Red Blood Cell Exchange Transfusion for Severe Babesiosis. JAMA Internal Medicine. 2026;186(5):597. doi:10.1001/jamainternmed.2026.0244

BibTeX
@article{STOPBABESIOSISInvestigators2026,
  author = {STOP-BABESIOSIS Investigators, STOP-BABESIOSIS Investigators and Leaf, David E and Monson, Audrey E and Dias, Julie-Alexia and Marcos, Luis A and Wu, Ulysses and Rossi, Michael and Ng, Jia H and Patell, Rushad and Hundert, Joshua and El Khoury, Marc Y and Higgs, James and Smith, Robert P and Ramsaroop, Vishali and Green, Adam and Abdul Azim, Ahmed and Weisenberg, Scott and Kirkman, Laura A and Ingram, David and Hsu, Caroline M and Dieckhaus, Kevin and Hyson, Peter and Burger, Zoe and Chengsupanimit, Tayoot and Stalmack, Tammy and Aber, Rachel and Golden, Marjorie and Koshy, Maria and Wright, Kendall and Cortezzo, Grace and McLeod, Gavin and Wenzel-Rideout, Rebecca and Baigorri, Julio Javier and Bagchi, Aranya and Jaser, Ahmad and Socorro Matos, Guillermo and Sanchez-Almanzar, Daniel and Hoge, Steven T and Shenoy, Tushar and Krishnamurthy, Shobana and Kaunfer, Sarah A and Blau, Jack A and Woolley, Ann and Zamor, Rudline and Maczaj, Brigitte and Kenison, David and Totten, Arthur and Bateman, Victoria and Mohsin, Sabrina and Lee, Eun Sun and Garner, Joseph and Rath, Payal and Wu, Quinlan and Guermazi, Dorra and London, Abby and Arvanitis, Panos and Yune, Philip S and Abdullah, Mahie and Kim, Angela and Roy, Juby},
  title = {Red Blood Cell Exchange Transfusion for Severe Babesiosis},
  journal = {JAMA Internal Medicine},
  year = {2026},
  volume = {186},
  number = {5},
  pages = {597},
  doi = {10.1001/jamainternmed.2026.0244}
}
Kostenlos starten →